Literature DB >> 28487679

Molecular Evolution of the RNA-Dependent RNA Polymerase and Capsid Genes of Human Norovirus Genotype GII.2 in Japan during 2004-2015.

Fuminori Mizukoshi1, Koo Nagasawa2, Yen H Doan3, Kei Haga4, Shima Yoshizumi5, Yo Ueki6, Michiyo Shinohara7, Mariko Ishikawa8, Naomi Sakon9, Naoki Shigemoto10, Reiko Okamoto-Nakagawa11, Akie Ochi12, Koichi Murakami2, Akihide Ryo13, Yoshiyuki Suzuki14, Kazuhiko Katayama4, Hirokazu Kimura2,13.   

Abstract

The RNA-dependent RNA polymerase (RdRp) and capsid (VP1) genes of 51 GII.2 human norovirus (HuNoV) strains collected during the period of 2004-2015 in Japan were analyzed. Full-length analyses of the genes were performed using next-generation sequencing. Based on the gene sequences, we constructed the time-scale evolutionary trees by Bayesian Markov chain Monte Carlo methods. Time-scale phylogenies showed that the RdRp and VP1 genes evolved uniquely and independently. Four genotypes of GII.2 (major types: GII.P2-GII.2 and GII.P16-GII.2) were detected. A common ancestor of the GII.2 VP1 gene existed until about 1956. The evolutionary rates of the genes were high (over 10-3 substitutions/site/year). Moreover, the VP1 gene evolution may depend on the RdRp gene. Based on these results, we hypothesized that transfer of the RdRp gene accelerated the VP1 gene evolution of HuNoV genotype GII.2. Consequently, recombination between ORF1 (polymerase) and ORF2 (capsid) might promote changes of GII.2 antigenicity.

Entities:  

Keywords:  RNA-dependent RNA polymerase; capsid; molecular epidemiology; molecular evolution; norovirus; phylogeny

Year:  2017        PMID: 28487679      PMCID: PMC5403926          DOI: 10.3389/fmicb.2017.00705

Source DB:  PubMed          Journal:  Front Microbiol        ISSN: 1664-302X            Impact factor:   5.640


Introduction

Human norovirus (HuNoV) is a major causative agent of gastroenteritis in humans (Green, 2013). The HuNoV genogroup II (GII), in particular, is frequently detected in outbreaks. The HuNoV GII strains can be classified into 22 genotypes (Kroneman et al., 2013). Moreover, the most worldwide prevalent HuNoV GII genotypes belong to GII genotype 2 (GII.2), GII.3, GII.4, GII.6, and GII.17 (Centers for Disease Control and Prevention. CaliciNet Data [cited 2016]). Since national surveillance began, nearly 3 million cases of NoV gastroenteritis have been recorded, and Japan was experiencing its second most serious norovirus outbreak during November 2016 to February 2017 (National Institute of Infectious Diseases. Japan. Infectious Gastroenteritis. [cited 4th April 2017, in Japanese]) Importantly, HuNoV GII.2 emerged as a major cause of this outbreak in Japan, although the GII.4 strains were the most prevalent genotype during the past 10 years (National Institute of Infectious Diseases. Japan. Flash report of norovirus in Japan [cited 4th April 2017, in Japanese]). Very recent studies suggested that the evolutionary patterns of human and animal NoV genotypes are distinct (Kobayashi et al., 2015, 2016). Although all viral proteins may act as antigens, the HuNoV VP1 protein is also involved in viral infection. Furthermore, HuNoV frequently experiences recombination at the ORF1/ORF2 junction, resulting in new chimera viruses with different types of the RNA-dependent RNA polymerase (RdRp) genes and capsid (VP1) genes. Most studies have focused on the molecular evolution of HuNoV GII.4. Only a few examined that gene in other HuNoV genotypes, including GII.2. To gain insight into this process, we examined the molecular evolution of the GII.2 RdRp and VP1 genes, including chimera viruses, based on the full genome analyses of those detected in Japan over a period of 10 years (2004–2015 seasons).

Materials and methods

To investigate the molecular evolution of the HuNoV VP1 and RdRp genes, 950 stool specimens were collected from various areas (13 prefectures) of Japan during the 2004–2015 seasons. These samples were obtained from patients with acute gastroenteritis due to HuNoV infections, in compliance with the Food Sanitation Law and the Law Concerning the Prevention of Infections and Medical Care for Patients of Infections of Japan. The personal data related to these samples were anonymized. RNA was extracted from 10% PBS suspensions of the specimens, and the HuNoV genomes were comprehensively analyzed by next-generation sequencing as described (Matsushima et al., 2015). Of 950 samples, the complete genome sequences of 538 strains were obtained (a success rate of 57%). Next, HuNoV genotypes were confirmed with the Norovirus Typing Tool (Version1.0), based on the nucleotide sequences of RdRp and VP1 genes as described by Kroneman et al. (2011). GII.2 strains were selected from these all genotyped strains, and then a few of strains having the undetermined base sequences (e.g., N, Y, R, and V) were omitted. Finally, 51 GII.2 strains were used for evolutionary analyses for the present study (Supplementary Table 1). The obtained nucleotide sequences for the GII.2 strains were deposited in GenBank under the accession numbers LC209431 to LC209481. Time-scale evolutionary analyses were performed using the Bayesian Markov Chain Monte Carlo method (MCMC) with the BEAST package v1.8.3 (Drummond and Rambaut, 2007) and Tracer as a demographic model. Substitution models were calculated with Kakusan4 (Tanabe, 2011). The substitution model for the VP1 or the RdRp gene was the GTR-Γ or GTR-Γ invariant model, respectively. Based on Akaike's Information Criterion for MCMC values, we used the random local clock as a clock model, and used the logistic growth model (VP1 gene) or the constant size model (RdRp gene) as a tree model. Convergence was evaluated with an effective sample size (acceptable more than 200). The MCMC chain length was 3 × 108 steps with sampling every 1,000 steps for the MCMC tree of the VP1 gene. To exactly estimate the evolutionary rates and topologies of the MCMC tree of the RdRp gene, we bound two independent data of the MCMC chains. The MCMC chain length was 2 × 108 steps and 4 × 108 with sampling every 5,000 steps for the MCMC tree of the RdRp gene. Statistical analyses were performed with the Welch's t-test in Excel 2013.

Results and discussion

Distribution of GII.2 genotype during the 2004–2015 seasons

Four genotypes of the GII.2 strains, including GII.P2-GII.2 (13 strains), GII.Pe-GII.2 (one strain), GII.P12-GII.2 (one strain), and GII.P16-GII.2 (36 strains), were determined by the Norovirus Typing Tool (Figure 1). Of them, GII.P16-GII.2 strains were the most prevalent genotype after 2009. The single GII.P12-GII.2 and GII.Pe-GII.2 strains were detected in 2004 and 2014 respectively. The GII.P2-GII.2 strains were detected throughout the investigation periods.
Figure 1

Distribution of GII.2 genotype during the investigation periods (2004–2015 seasons).

Distribution of GII.2 genotype during the investigation periods (2004–2015 seasons).

Phylogenetic analysis and evolutionary rates of VP1 and RdRp virus genes

Based on the VP1 gene sequences, we constructed a time-scale evolutionary tree (Figure 2A). The phylogeny of the VP1 gene showed that GII.2 strains could be divided according to the type of RdRp gene. GII.P16-GII.2 could be subdivided into three clusters of strains in 2009–2010, 2010–2012, and 2012–2014. In addition, the phylogenetic divergence of the GII.P16-GII.2 strains might be wider than that of the GII.P2-GII.2 strains. The tree shows that the most recent common ancestor (MRCA) of the present GII.2 strains appeared in 1956 (mean ± 95% highest posterior densities [HPD]: 1945–1966). Subsequently, GII.P2-GII.2 virus strain emerged in 2000 (mean ± 95% HPD: 1998–2001). Moreover, the GII.P16-GII.2 strains detected in 2010–2012 diverged from a common ancestor of the GII.P2-GII.2 strains at 2002 (mean ± 95% HPD: 2001–2004). The GII.P16-GII.2 strains detected in 2009–2010 and 2012–2014 diverged at 2005 (mean ± 95% HPD: 2004–2007). The evolutionary rate of these VP1 genes was 2.987 × 10−3 substitutions/site/year (mean ± 95% HPD: 2.496–3.486 × 10−3 substitutions/site/year).
Figure 2

Phylogenetic trees of and RdRp (B) genes of the genotype GII.2 constructed by the Bayesian MCMC method. We analyzed VP1 gene of 50 strains, and RdRp gene of 49 strains, excluding 100%—matched homologous strains. Reference strains in these trees were indicated in bold letters. Gray bar shows 95% HPD. The scale bar represents actual time (year).

Phylogenetic trees of and RdRp (B) genes of the genotype GII.2 constructed by the Bayesian MCMC method. We analyzed VP1 gene of 50 strains, and RdRp gene of 49 strains, excluding 100%—matched homologous strains. Reference strains in these trees were indicated in bold letters. Gray bar shows 95% HPD. The scale bar represents actual time (year). We also constructed a time-scale evolutionary tree of the RdRp gene (Figure 2B). The tree shows that the MRCA of RdRp of the present GII.2 strains was in the year 1696 (mean ± 95% HPD: 1542–1837). The common ancestor of the GII.P16-GII.2 strains diverged in 1858 (mean ± 95% HPD: 1747–1950) and formed two clusters. Moreover, the GII.P16-GII.2 strains detected in 2010–2012 diverged at 1989 (mean ± 95% HPD: 1972–2003), whereas the GII.P16-GII.2 strains detected in 2009–2010 and 2012–2014 diverged at 1986 (mean ± 95% HPD: 1968–2002). The common ancestor of the GII.P2-GII.2, GII.P12-GII.2, and GII.Pe-GII.2 diverged in 1828 (mean ± 95% HPD: 1741–1913). The RdRp gene of GII.P2-GII.2 diverged in 1992 (mean ± 95% HPD: 1984–2000). The evolutionary rate of these RdRp genes was 1.314 × 10−3 substitutions/site/year (mean ± 95% HPD: 0.698–1.95 × 10−3 substitutions/site/year). Next, we compared the evolutionary rates of the GII.P16-GII.2 and GII.P2-GII.2 strains. To gain statistical significance, we collected the nucleotide sequences of the GII.P2-GII.2 strains (25 strains) from GenBank, but we could not collect a sufficient number of the GII.P12-GII.2 and GII.Pe-GII.2 sequences from the GenBank to reach statistical significance. The evolutionary rate of GII.P16-GII.2 (1.838 × 10−3 substitutions/site/year; mean ± 95% HPD: 1.237–2.456 × 10−3 substitutions/site/year) was greater than that of GII.P2-GII.2 (1.712 × 10−3 substitutions/site/year; mean ± 95% HPD: 0.957–2.41 × 10−3 substitutions/site/year) (p = 7.891 × 10−135). A previous report suggested that the evolution of VP1 may be influenced by the activities of RdRp (Bull et al., 2010). Collectively, our bioinformatics data also showed that the evolution of the GII.2 VP1 gene was accelerated by a recombination of ORF1, including the RdRp gene. However, additional in vitro studies regarding the mutation rates of RdRp of the GII.P2 and GII.P16 may be needed to clarify the hypothesis of the relationships between and VP1 and RdRp genes in this study. Furthermore, GII.2 variant strains were detected in the present season (2016/17 season), and thus, further genetic studies may be needed to prove this hypothesis.

Conclusions

Here we report the molecular evolution of the VP1 and RdRp genes in HuNoV GII.2. Our main findings and hypothesis are as follows. (1) Four genotypes of GII.2 (GII.P2-GII.2, GII.P16-GII.2, GII.P12-GII.2, and GII.Pe-GII.2) were detected in Japan in 2004–2015. (2) A common ancestor of the current GII.2 virus strains circulated around 1956. (3) VP1 gene evolution seems to depend on the RdRp gene. The VP1 gene in a prevalent HuNoV genotype GII.2 might evolve uniquely by transfer of the RdRp gene.

Ethics statement

This study protocol was approved by the National Institute of Infectious Diseases Ethics Committee (No. 532).

Author contributions

FM designed and performed the research, analyzed the data and wrote the manuscript. KN, YD, and KH performed the research and analyzed the data. FM, SY, YU, MS, MI, NS (Sakon), NS (Shigemoto), RO, and AO contributed samples and analyzed the data; and HK and KK designed and supervised the research, analyzed the data, and wrote the manuscript. All authors contributed, read, and approved the manuscript.

Funding

This work was partly supported by a commissioned project for Research on Emerging and Re-emerging Infectious Diseases from Japan Agency for Medical Research and Development, AMED.

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
  8 in total

1.  An automated genotyping tool for enteroviruses and noroviruses.

Authors:  A Kroneman; H Vennema; K Deforche; H v d Avoort; S Peñaranda; M S Oberste; J Vinjé; M Koopmans
Journal:  J Clin Virol       Date:  2011-04-21       Impact factor: 3.168

2.  Kakusan4 and Aminosan: two programs for comparing nonpartitioned, proportional and separate models for combined molecular phylogenetic analyses of multilocus sequence data.

Authors:  Akifumi S Tanabe
Journal:  Mol Ecol Resour       Date:  2011-05-19       Impact factor: 7.090

3.  Genetic analyses of GII.17 norovirus strains in diarrheal disease outbreaks from December 2014 to March 2015 in Japan reveal a novel polymerase sequence and amino acid substitutions in the capsid region.

Authors:  Y Matsushima; M Ishikawa; T Shimizu; A Komane; S Kasuo; M Shinohara; K Nagasawa; H Kimura; A Ryo; N Okabe; K Haga; Y H Doan; K Katayama; H Shimizu
Journal:  Euro Surveill       Date:  2015-07-02

4.  Proposal for a unified norovirus nomenclature and genotyping.

Authors:  Annelies Kroneman; Everardo Vega; Harry Vennema; Jan Vinjé; Peter A White; Grant Hansman; Kim Green; Vito Martella; Kazuhiko Katayama; Marion Koopmans
Journal:  Arch Virol       Date:  2013-04-25       Impact factor: 2.574

5.  Rapid evolution of pandemic noroviruses of the GII.4 lineage.

Authors:  Rowena A Bull; John-Sebastian Eden; William D Rawlinson; Peter A White
Journal:  PLoS Pathog       Date:  2010-03-26       Impact factor: 6.823

6.  BEAST: Bayesian evolutionary analysis by sampling trees.

Authors:  Alexei J Drummond; Andrew Rambaut
Journal:  BMC Evol Biol       Date:  2007-11-08       Impact factor: 3.260

7.  Molecular Evolution of the Capsid Gene in Norovirus Genogroup I.

Authors:  Miho Kobayashi; Shima Yoshizumi; Sayaka Kogawa; Tomoko Takahashi; Yo Ueki; Michiyo Shinohara; Fuminori Mizukoshi; Hiroyuki Tsukagoshi; Yoshiko Sasaki; Rieko Suzuki; Hideaki Shimizu; Akira Iwakiri; Nobuhiko Okabe; Komei Shirabe; Hiroto Shinomiya; Kunihisa Kozawa; Hideki Kusunoki; Akihide Ryo; Makoto Kuroda; Kazuhiko Katayama; Hirokazu Kimura
Journal:  Sci Rep       Date:  2015-09-04       Impact factor: 4.379

8.  Molecular evolution of the capsid gene in human norovirus genogroup II.

Authors:  Miho Kobayashi; Yuki Matsushima; Takumi Motoya; Naomi Sakon; Naoki Shigemoto; Reiko Okamoto-Nakagawa; Koichi Nishimura; Yasutaka Yamashita; Makoto Kuroda; Nobuhiro Saruki; Akihide Ryo; Takeshi Saraya; Yukio Morita; Komei Shirabe; Mariko Ishikawa; Tomoko Takahashi; Hiroto Shinomiya; Nobuhiko Okabe; Koo Nagasawa; Yoshiyuki Suzuki; Kazuhiko Katayama; Hirokazu Kimura
Journal:  Sci Rep       Date:  2016-07-07       Impact factor: 4.379

  8 in total
  11 in total

Review 1.  Emergence of norovirus strains: A tale of two genes.

Authors:  Gabriel I Parra
Journal:  Virus Evol       Date:  2019-11-25

2.  Genetic Analysis of an Emerging GII.P2-GII.2 Norovirus Associated with a 2016 Outbreak of Acute Gastroenteritis in China.

Authors:  Yuanyun Ao; Xiaolu Xie; Xiaogen Dong; Miao Jin; Zhaojun Duan
Journal:  Virol Sin       Date:  2019-02-06       Impact factor: 4.327

3.  Norovirus strains in patients with acute gastroenteritis in rural and low-income urban areas in northern Brazil.

Authors:  Rory J Tinker; Antonio Charlys da Costa; Roozbeh Tahmasebi; Eric Delwart; Ester Cerdeira Sabino; Elcio Leal; Adriana Luchs; Flavio Augusto de Pádua Milagres; Vanessa Dos Santos Morais; Ramendra Pati Pandey; Alexis José-Abrego; Rafael Brustulin; Maria da Aparecida Rodrigues Teles; Mariana Sequetin Cunha; Emerson Luiz Lima Araújo; Mariela Martínez Gómez; Xutao Deng
Journal:  Arch Virol       Date:  2021-01-19       Impact factor: 2.574

4.  Antigenic Characterization of a Novel Recombinant GII.P16-GII.4 Sydney Norovirus Strain With Minor Sequence Variation Leading to Antibody Escape.

Authors:  Lisa C Lindesmith; Paul D Brewer-Jensen; Michael L Mallory; Kari Debbink; Excel W Swann; Jan Vinjé; Ralph S Baric
Journal:  J Infect Dis       Date:  2018-03-13       Impact factor: 5.226

5.  Molecular Evolution of the VP1 Gene in Human Norovirus GII.4 Variants in 1974-2015.

Authors:  Takumi Motoya; Koo Nagasawa; Yuki Matsushima; Noriko Nagata; Akihide Ryo; Tsuyoshi Sekizuka; Akifumi Yamashita; Makoto Kuroda; Yukio Morita; Yoshiyuki Suzuki; Nobuya Sasaki; Kazuhiko Katayama; Hirokazu Kimura
Journal:  Front Microbiol       Date:  2017-12-05       Impact factor: 5.640

6.  Genetic Analysis of Human Norovirus Strains in Japan in 2016-2017.

Authors:  Koo Nagasawa; Yuki Matsushima; Takumi Motoya; Fuminori Mizukoshi; Yo Ueki; Naomi Sakon; Koichi Murakami; Tomomi Shimizu; Nobuhiko Okabe; Noriko Nagata; Komei Shirabe; Hiroto Shinomiya; Wataru Suzuki; Makoto Kuroda; Tsuyoshi Sekizuka; Yoshiyuki Suzuki; Akihide Ryo; Kiyotaka Fujita; Kazunori Oishi; Kazuhiko Katayama; Hirokazu Kimura
Journal:  Front Microbiol       Date:  2018-01-18       Impact factor: 5.640

7.  Detection and molecular characterization of the novel recombinant norovirus GII.P16-GII.4 Sydney in southeastern Brazil in 2016.

Authors:  Débora Maria Pires Gonçalves Barreira; Túlio Machado Fumian; Marco André Loureiro Tonini; Lays Paula Bondi Volpini; Rodrigo Pratte Santos; Anézia Lima Chaves Ribeiro; José Paulo Gagliardi Leite; Márcia Terezinha Baroni de Moraes E Souza; Patrícia Brasil; Denise Cotrim da Cunha; Marize Pereira Miagostovich; Liliana Cruz Spano
Journal:  PLoS One       Date:  2017-12-13       Impact factor: 3.240

8.  High transmissibility of norovirus among infants and school children during the 2016/17 season in Osaka, Japan.

Authors:  Naomi Sakon; Jun Komano; Heidi L Tessmer; Ryosuke Omori
Journal:  Euro Surveill       Date:  2018-02

9.  Variation of human norovirus GII genotypes detected in Ibaraki, Japan, during 2012-2018.

Authors:  Takumi Motoya; Masahiro Umezawa; Aoi Saito; Keiko Goto; Ikuko Doi; Setsuko Fukaya; Noriko Nagata; Yoshiaki Ikeda; Kaori Okayama; Jumpei Aso; Yuki Matsushima; Taisei Ishioka; Akihide Ryo; Nobuya Sasaki; Kazuhiko Katayama; Hirokazu Kimura
Journal:  Gut Pathog       Date:  2019-05-24       Impact factor: 4.181

10.  Emergence of norovirus GII.P16-GII.2 strains in patients with acute gastroenteritis in Huzhou, China, 2016-2017.

Authors:  Jiankang Han; Xiaofang Wu; Liping Chen; Yun Fu; Deshun Xu; Peng Zhang; Lei Ji
Journal:  BMC Infect Dis       Date:  2018-07-24       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.